Candriam Equities L Oncology Impact R/ LU1864482861 /
| NAV16/05/2024 | Var.+0.1800 | Type of yield | Focus sugli investimenti | Società d'investimento |
|---|---|---|---|---|
| 191.3300USD | +0.09% | paying dividend | Equity Worldwide | Candriam ▶ |
Performance mensile
| gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic | Totale | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | -1.46 | -5.36 | -3.08 | 12.11 | 8.53 | 1.40 | 4.43 | 2.14 | 3.50 | -2.21 | 5.80 | 3.85 | +32.28% |
| 2021 | 0.54 | -4.21 | -0.10 | 2.32 | 0.17 | 3.52 | -0.97 | 5.58 | -3.78 | 3.36 | -6.38 | 3.98 | +3.34% |
| 2022 | -10.50 | -1.76 | 4.64 | -5.86 | -1.34 | 0.04 | 4.36 | -3.15 | -4.72 | 7.03 | 6.07 | -3.45 | -9.76% |
| 2023 | 2.15 | -3.89 | 1.37 | 2.82 | -2.57 | 0.07 | 0.88 | -2.02 | -5.25 | -6.36 | 9.21 | 5.72 | +1.01% |
| 2024 | 1.36 | 4.14 | 1.48 | -3.39 | 5.00 | - | - | - | - | - | - | - | - |
Mesi singoli: Dividendi non considerati
Calculated values
| YTD | 6 mesi | 1 anno | 3 anni | 5 anni | |
|---|---|---|---|---|---|
| Volatilità | 10.88% | 10.93% | 11.81% | 14.68% | -% |
| Indice di Sharpe | 1.96 | 3.50 | 0.28 | -0.15 | - |
| Mese migliore | +5.72% | +9.21% | +9.21% | +9.21% | +12.11% |
| Mese peggiore | -3.39% | -3.39% | -6.36% | -10.50% | -10.50% |
| Perdita massima | -6.79% | -6.79% | -15.93% | -25.23% | - |
| Outperformance | - | - | - | - | - |
Tutte le quotazioni in USD
Tranches
| Nome | Type of yield | Prezzo di riacquisto | 1 anno | 3 anni | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,400.9099 | +7.62% | +6.05% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,565.5000 | +7.75% | +6.45% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.9700 | +4.02% | -4.87% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,252.5000 | +5.81% | +17.09% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,611.3000 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | reinvestment | 245.4500 | +6.23% | +14.09% | |
| Candriam Equities L Oncology Imp... | paying dividend | 236.2900 | +6.27% | +2.13% | |
| Candriam Equities L Oncology Imp... | paying dividend | 191.3300 | +7.17% | +4.73% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,796.0000 | +3.23% | +2.32% | |
| Candriam Equities L Oncology Imp... | reinvestment | 159.3600 | +5.69% | +16.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,114.3201 | +5.00% | -2.15% | |
| Candriam Equities L Oncology Imp... | reinvestment | 260.0600 | +7.14% | +17.01% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.4600 | +3.60% | -5.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.8900 | +7.16% | +4.72% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.1900 | +4.88% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,857.8800 | +6.15% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,884.1399 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.8100 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 274.5300 | +6.26% | +2.11% |
Prestazione
| YTD | +8.66% | ||
|---|---|---|---|
| 6 mesi | +19.01% | ||
| 1 anno | +7.17% | ||
| 3 anni | +4.73% | ||
| 5 anni | - | ||
| 10 anni | - | ||
| Dall'inizio | +36.79% | ||
| Anno | |||
| 2023 | +1.01% | ||
| 2022 | -9.76% | ||
| 2021 | +3.34% | ||
| 2020 | +32.28% | ||
Dividendi
| 29/04/2024 | 3.64 USD |
| 28/04/2023 | 2.69 USD |
| 28/04/2022 | 3.36 USD |
| 28/04/2021 | 3.25 USD |
